Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AARSD1,Alanyl-tRNA editing protein Aarsd1,22605,154,1.48 [1.17-1.89],0.0011975906054474
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ABRAXAS2,BRISC complex subunit Abraxas 2,19168,129,1.37 [1.07-1.75],0.0122313840355721
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACRBP,Acrosin-binding protein,19665,134,1.60 [1.11-2.30],0.01240499807361
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACTA2,"Actin, aortic smooth muscle",22305,153,1.46 [1.13-1.89],0.0034891724309539
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACVRL1,Serine/threonine-protein kinase receptor R3,22523,153,3.05 [1.78-5.21],4.542911821524224e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACYP1,Acylphosphatase-1,19275,132,1.36 [1.06-1.74],0.0137096975025855
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADA,Adenosine deaminase,22959,157,1.80 [1.27-2.55],0.0010516357493143
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADA2,Adenosine deaminase 2,22554,157,1.62 [1.18-2.23],0.0030498595125234
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,19221,132,1.48 [1.02-2.14],0.0387378060808577
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,22305,153,2.59 [1.63-4.11],5.846481044870527e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,22866,153,4.18 [2.83-6.18],6.938891831858296e-13
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,19221,132,1.55 [1.02-2.34],0.0385710294293751
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAMTSL5,ADAMTS-like protein 5,19770,134,0.59 [0.39-0.90],0.0142040836521921
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRE1,Adhesion G protein-coupled receptor E1,19671,134,2.10 [1.63-2.71],8.669545154562666e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRE5,Adhesion G protein-coupled receptor E5,22876,159,1.71 [1.12-2.62],0.0135917265338117
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRF5,Adhesion G protein-coupled receptor F5,19770,134,1.76 [1.01-3.07],0.0443752734431619
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,22305,153,1.18 [1.01-1.40],0.0427335788178954
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AGT,Angiotensinogen,19775,135,0.65 [0.46-0.91],0.0116183374940603
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AKR1C4,Aldo-keto reductase family 1 member C4,22305,153,1.26 [1.04-1.53],0.0207180297485178
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AKT1S1,Proline-rich AKT1 substrate 1,22146,152,1.27 [1.03-1.58],0.0276328909713212
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ALCAM,CD166 antigen,22983,159,2.61 [1.28-5.30],0.0080330420176932
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ALDH2,"Aldehyde dehydrogenase, mitochondrial",19665,134,1.31 [1.05-1.63],0.0187445789001494
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",19741,135,1.40 [1.04-1.89],0.027273206591966
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMIGO2,Amphoterin-induced protein 2,22605,154,2.18 [1.16-4.10],0.0160133784072773
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMOTL2,Angiomotin-like protein 2,19607,134,1.33 [1.02-1.75],0.0372267584373728
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANGPT2,Angiopoietin-2,22910,156,1.86 [1.32-2.63],0.0004119685672755
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,19267,128,1.40 [1.06-1.85],0.0182785437883133
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANXA2,Annexin A2,18976,128,1.34 [1.11-1.63],0.0028919731766734
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AOC3,Membrane primary amine oxidase,22773,157,0.61 [0.39-0.95],0.0305513164181985
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AP2B1,AP-2 complex subunit beta,19219,128,1.51 [1.14-2.00],0.0044885186308579
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AP3S2,AP-3 complex subunit sigma-2,19732,135,1.46 [1.06-2.01],0.0195959133676173
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,22605,154,1.46 [1.13-1.87],0.0036118414384353
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,22837,156,1.33 [1.07-1.66],0.0102401207374009
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APLP1,Amyloid-like protein 1,22711,157,0.72 [0.55-0.96],0.0230962495388154
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOA1,Apolipoprotein A-I,19799,134,0.35 [0.18-0.71],0.0036552456028668
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOBR,Apolipoprotein B receptor,19267,128,0.58 [0.40-0.84],0.0042801801562337
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOC1,Apolipoprotein C-I,19754,133,0.50 [0.30-0.83],0.0067612158961689
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOD,Apolipoprotein D,18881,126,0.58 [0.34-0.98],0.0400280653650455
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOM,Apolipoprotein M,22736,157,0.32 [0.20-0.52],4.118097012967073e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AREG,Amphiregulin,22605,154,1.38 [1.05-1.82],0.0227646924835195
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARHGEF1,Rho guanine nucleotide exchange factor 1,19732,135,1.21 [1.00-1.45],0.0469581335118699
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARNT,Aryl hydrocarbon receptor nuclear translocator,22280,152,1.48 [1.10-1.98],0.0086482989196878
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARSB,Arylsulfatase B,22605,154,1.40 [1.09-1.79],0.0077970179293486
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ASAH1,Acid ceramidase,19582,133,1.36 [1.02-1.82],0.0338712999908567
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ASGR1,Asialoglycoprotein receptor 1,22558,153,2.20 [1.39-3.46],0.0006933073068822
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ASPN,Asporin,19770,134,0.43 [0.22-0.83],0.0121412125675633
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ASPSCR1,Tether containing UBX domain for GLUT4,19741,135,1.28 [1.01-1.63],0.0411414709003579
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATG4A,Cysteine protease ATG4A,22194,151,1.26 [1.00-1.59],0.0472094533282538
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,19168,129,1.54 [1.02-2.34],0.041651587456314
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATRAID,All-trans retinoic acid-induced differentiation factor,19671,134,1.46 [1.06-2.00],0.0204697329268766
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATXN10,Ataxin-10,22146,152,1.28 [1.04-1.57],0.0180210930865543
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATXN2L,Ataxin-2-like protein,19741,135,1.39 [1.05-1.85],0.023465499755015
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",B2M,Beta-2-microglobulin,19799,134,1.63 [1.33-2.00],3.216449792516352e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",B4GALT1,"Beta-1,4-galactosyltransferase 1",22813,156,2.04 [1.23-3.37],0.005607323737778
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAG4,BAG family molecular chaperone regulator 4,19221,132,1.36 [1.00-1.84],0.0483491826646669
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAG6,Large proline-rich protein BAG6,22305,153,1.49 [1.01-2.20],0.044994572946123
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,22194,151,1.28 [1.04-1.58],0.0204379134301863
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAMBI,BMP and activin membrane-bound inhibitor homolog,22194,151,1.70 [1.10-2.63],0.0171616561466101
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAP18,Chromatin complexes subunit BAP18,19732,135,1.35 [1.14-1.61],0.0006529003332963
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAX,Apoptosis regulator BAX,22116,152,1.18 [1.00-1.38],0.0448343367039085
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",19770,134,1.66 [1.07-2.58],0.022920157958196
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCL2,Apoptosis regulator Bcl-2,19671,134,1.93 [1.68-2.20],1.3871263016032942e-21
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCL7A,B-cell CLL/lymphoma 7 protein family member A,19073,128,1.28 [1.05-1.56],0.0130984674926167
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BLNK,B-cell linker protein,19221,132,1.83 [1.40-2.40],1.0408542641614297e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,19162,131,1.26 [1.06-1.50],0.0089442938876934
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BMPER,BMP-binding endothelial regulator protein,19358,132,2.11 [1.16-3.82],0.0138205827017104
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,19221,132,1.67 [1.21-2.28],0.0015350246513462
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BOLA2_BOLA2B,BolA-like protein 2,19267,128,1.61 [1.19-2.19],0.0021713760043927
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BSG,Basigin,22918,156,2.41 [1.17-4.95],0.0165259117675793
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BTN2A1,Butyrophilin subfamily 2 member A1,22813,156,3.14 [1.96-5.05],2.135613568709821e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BTN3A2,Butyrophilin subfamily 3 member A2,22671,156,1.95 [1.47-2.59],3.837455657350311e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1QA,Complement C1q subcomponent subunit A,22841,156,3.02 [1.66-5.49],0.0002844178473057
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1QL2,Complement C1q-like protein 2,19221,132,1.61 [1.22-2.13],0.0008531411897031
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,19741,135,1.61 [1.09-2.38],0.0179035916405433
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1RL,Complement C1r subcomponent-like protein,19767,134,5.53 [2.38-12.88],7.210792829150061e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C2,Complement C2,22736,157,0.61 [0.46-0.82],0.0009237143038441
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C4BPB,C4b-binding protein beta chain,22777,154,1.50 [1.07-2.11],0.0185771253842188
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C7,Complement component C7,19321,131,2.18 [1.26-3.77],0.0052190904317964
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C9,Complement component C9,19775,135,1.63 [1.14-2.31],0.0065910736311813
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA12,Carbonic anhydrase 12,22605,154,1.73 [1.17-2.56],0.0064459321563335
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA5A,"Carbonic anhydrase 5A, mitochondrial",22305,153,1.22 [1.06-1.41],0.0054000217084466
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA6,Carbonic anhydrase 6,22645,155,0.74 [0.59-0.92],0.0076680298574979
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CALCA,Calcitonin,22510,153,1.36 [1.09-1.69],0.0054617460017328
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,19267,128,1.28 [1.04-1.59],0.020305927160625
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,22194,151,1.40 [1.04-1.90],0.0286061979591926
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CANT1,Soluble calcium-activated nucleotidase 1,22643,155,5.53 [2.79-10.96],9.181327592024468e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASC3,Protein CASC3,19219,128,1.65 [1.15-2.36],0.0067484048470656
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASP7,Caspase-7,19732,135,1.26 [1.04-1.53],0.0205599438683253
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CBX2,Chromobox protein homolog 2,19168,129,1.49 [1.14-1.96],0.0038929298233729
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCDC50,Coiled-coil domain-containing protein 50,19741,135,1.23 [1.04-1.45],0.0173493502872834
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL14,C-C motif chemokine 14,22628,157,1.66 [1.24-2.22],0.000658429186245
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL15,C-C motif chemokine 15,22983,159,1.73 [1.30-2.30],0.0001419287825161
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL17,C-C motif chemokine 17,22678,156,1.30 [1.12-1.52],0.0006465606037374
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL18,C-C motif chemokine 18,22363,156,1.27 [1.08-1.50],0.0044999381020587
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL19,C-C motif chemokine 19,22906,153,1.13 [1.03-1.23],0.0072632257101489
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL21,C-C motif chemokine 21,22813,156,1.63 [1.32-2.00],3.7864637700984025e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL22,C-C motif chemokine 22,22487,156,1.50 [1.18-1.91],0.0010568880353324
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL26,C-C motif chemokine 26,22671,156,1.15 [1.01-1.31],0.0316078224760064
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL3,C-C motif chemokine 3,22671,156,1.37 [1.20-1.56],2.413069350094e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL4,C-C motif chemokine 4,22745,156,1.18 [1.00-1.38],0.0467392495623557
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL7,C-C motif chemokine 7,22671,156,1.25 [1.02-1.52],0.0300978489117118
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL8,C-C motif chemokine 8,22877,156,1.38 [1.09-1.74],0.007846833172873
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCN4,CCN family member 4,22910,156,1.77 [1.31-2.40],0.0002215665442265
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCNE1,G1/S-specific cyclin-E1,19221,132,1.20 [1.06-1.37],0.004286702671223
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD14,Monocyte differentiation antigen CD14,22211,157,1.59 [1.16-2.18],0.0041535803882713
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD160,CD160 antigen,22959,157,1.75 [1.32-2.33],0.0001139088473713
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD1C,T-cell surface glycoprotein CD1c,22777,154,2.09 [1.13-3.86],0.018305996919529
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD2,T-cell surface antigen CD2,19168,129,1.54 [1.19-1.99],0.0009935718179784
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD200,OX-2 membrane glycoprotein,22671,156,2.36 [1.37-4.06],0.0019688352245801
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD200R1,Cell surface glycoprotein CD200 receptor 1,22603,156,2.32 [1.60-3.36],1.0095729440000577e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD22,B-cell receptor CD22,22959,157,4.08 [3.23-5.16],6.277863544823153e-32
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD244,Natural killer cell receptor 2B4,22959,157,1.79 [1.07-2.99],0.0254080201720927
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD27,CD27 antigen,22777,154,3.83 [2.93-5.02],1.9672658746731041e-22
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD274,Programmed cell death 1 ligand 1,22558,153,2.35 [1.75-3.16],1.6237129056109464e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD28,T-cell-specific surface glycoprotein CD28,22194,151,2.50 [2.07-3.02],2.367878656459647e-21
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD300A,CMRF35-like molecule 8,19358,132,1.80 [1.04-3.11],0.0362862995993415
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD300E,CMRF35-like molecule 2,22829,154,1.89 [1.36-2.61],0.0001288185805674
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD300LF,CMRF35-like molecule 1,22910,156,1.67 [1.28-2.19],0.0001954403428766
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD302,CD302 antigen,22605,154,2.40 [1.57-3.68],5.25678857923845e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,22605,154,2.18 [1.40-3.37],0.0005187720374476
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD3D,T-cell surface glycoprotein CD3 delta chain,19162,131,1.51 [1.10-2.07],0.0113125950238816
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD3E,T-cell surface glycoprotein CD3 epsilon chain,19390,131,1.39 [1.04-1.88],0.0286189598452228
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD4,T-cell surface glycoprotein CD4,22629,156,1.81 [1.39-2.35],1.0354456637443567e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD46,Membrane cofactor protein,22547,157,1.94 [1.28-2.93],0.0017035297014591
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD48,CD48 antigen,22774,156,2.88 [1.81-4.58],8.05987245088534e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD5,T-cell surface glycoprotein CD5,22877,156,4.13 [2.84-6.01],1.200887516813871e-13
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD59,CD59 glycoprotein,21868,149,1.85 [1.05-3.25],0.0320108823802389
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD5L,CD5 antigen-like,19681,133,2.34 [1.71-3.22],1.264373921403952e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD6,T-cell differentiation antigen CD6,22918,156,1.39 [1.07-1.81],0.0144148998236701
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD7,T-cell antigen CD7,19182,132,2.15 [1.68-2.75],1.299873057839825e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD70,CD70 antigen,22671,156,3.55 [2.73-4.61],2.515347336372589e-21
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,19358,132,4.65 [3.54-6.10],1.36971127151493e-28
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,22906,153,3.30 [2.36-4.63],4.293118191583146e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD79B,B-cell antigen receptor complex-associated protein beta chain,22959,157,4.24 [3.48-5.15],1.9097924720955519e-47
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,19770,134,7.36 [5.45-9.94],1.058121738014762e-38
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD82,CD82 antigen,19390,131,1.39 [1.04-1.87],0.0254176430995216
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD83,CD83 antigen,22671,156,5.89 [4.28-8.10],1.5424512663733731e-27
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD86,T-lymphocyte activation antigen CD86,19671,134,2.43 [1.41-4.18],0.0013441036586511
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDC27,Cell division cycle protein 27 homolog,22194,151,1.28 [1.03-1.60],0.0244426070687509
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDCP1,CUB domain-containing protein 1,22558,153,1.75 [1.35-2.26],1.8684202435669e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH3,Cadherin-3,22906,153,1.51 [1.03-2.20],0.033383814517379
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH5,Cadherin-5,22983,159,2.06 [1.34-3.16],0.0008969942245924
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDK1,Cyclin-dependent kinase 1,19073,128,1.70 [1.10-2.61],0.0164557627710409
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,19741,135,1.36 [1.06-1.75],0.0139682923709525
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,19390,131,1.39 [1.05-1.85],0.0221999633343488
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,22671,156,1.46 [1.26-1.70],6.079776616733674e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEBPA,CCAAT/enhancer-binding protein alpha,19221,132,1.50 [1.16-1.95],0.0021570726291785
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CENPF,Centromere protein F,19390,131,1.46 [1.14-1.88],0.0026975375596801
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEP164,Centrosomal protein of 164 kDa,22280,152,1.20 [1.02-1.43],0.0328667867815536
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEP85,Centrosomal protein of 85 kDa,22194,151,1.26 [1.01-1.56],0.0379497842365572
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CES1,Liver carboxylesterase 1,22757,158,0.82 [0.68-0.99],0.0427779938551012
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CES3,Carboxylesterase 3,22605,154,0.74 [0.59-0.94],0.0116850559959683
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFC1,Cryptic protein,22194,151,1.40 [1.07-1.81],0.0123285529322224
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,22194,151,1.36 [1.12-1.66],0.0021719484073705
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",19732,135,2.07 [1.52-2.84],4.896816208645879e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHGA,Chromogranin-A,19766,134,1.21 [1.04-1.42],0.0135059041872824
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CIT,Citron Rho-interacting kinase,19219,128,1.78 [1.38-2.28],6.4812748109794615e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CKAP4,Cytoskeleton-associated protein 4,22850,156,2.86 [1.94-4.21],1.2397014584660428e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CKB,Creatine kinase B-type,19766,134,1.66 [1.27-2.18],0.0002227728099207
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC12A,C-type lectin domain family 12 member A,19221,132,2.82 [1.72-4.64],4.188975688439581e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC1A,C-type lectin domain family 1 member A,22305,153,2.50 [1.67-3.73],7.96766975939359e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC4C,C-type lectin domain family 4 member C,22671,156,1.59 [1.19-2.12],0.0018938147524392
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC4G,C-type lectin domain family 4 member G,22671,156,2.35 [1.56-3.54],4.173192946100734e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC6A,C-type lectin domain family 6 member A,22194,151,1.70 [1.30-2.24],0.0001282763548317
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLGN,Calmegin,19219,128,1.42 [1.01-1.98],0.0416692462837746
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLSTN3,Calsyntenin-3,19732,135,2.87 [2.16-3.82],3.4726200084255577e-13
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLTA,Clathrin light chain A,22305,153,1.42 [1.11-1.82],0.0048923290853371
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLUL1,Clusterin-like protein 1,22680,157,0.72 [0.53-0.99],0.041788362092211
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",19230,128,1.29 [1.04-1.59],0.0191784347602187
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNTN3,Contactin-3,22717,155,0.50 [0.33-0.74],0.0004984936592859
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNTNAP4,Contactin-associated protein-like 4,19219,128,1.17 [1.03-1.34],0.0192087177661308
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COCH,Cochlin,19770,134,1.62 [1.16-2.24],0.0040288774220792
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL18A1,Collagen alpha-1(XVIII) chain,22807,159,2.10 [1.15-3.82],0.0157131639402958
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL24A1,Collagen alpha-1(XXIV) chain,19671,134,1.43 [1.05-1.97],0.025397878296793
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL2A1,Collagen alpha-1(II) chain,19267,128,1.32 [1.08-1.61],0.0059305139417884
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL5A1,Collagen alpha-1(V) chain,19358,132,1.50 [1.02-2.22],0.0416364837185866
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COLEC12,Collectin-12,22704,156,1.86 [1.08-3.20],0.0245562592542731
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COMMD1,COMM domain-containing protein 1,19267,128,1.34 [1.03-1.75],0.0305058475648985
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COMP,Cartilage oligomeric matrix protein,22446,157,0.57 [0.37-0.87],0.0084773966570165
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPTP,Ceramide-1-phosphate transfer protein,19168,129,1.52 [1.09-2.11],0.0128010082689866
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPXM1,Probable carboxypeptidase X1,22777,154,1.23 [1.01-1.50],0.0439195064593182
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CR1,Complement receptor type 1,19694,135,2.45 [1.58-3.81],6.80632545380776e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CR2,Complement receptor type 2,22773,157,2.72 [2.06-3.58],1.3199687636292497e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRTAM,Cytotoxic and regulatory T-cell molecule,22558,153,2.68 [2.07-3.48],1.2031054303576852e-13
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRYBB1,Beta-crystallin B1,19770,134,1.37 [1.07-1.76],0.0128451899965503
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSDE1,Cold shock domain-containing protein E1,19168,129,1.14 [1.01-1.29],0.0359808741288961
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,22813,156,3.30 [2.10-5.19],2.271052188124265e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF1R,Macrophage colony-stimulating factor 1 receptor,19775,135,2.00 [1.37-2.93],0.0003374932434821
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,22558,153,1.36 [1.11-1.65],0.002715013498013
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF2RB,Cytokine receptor common subunit beta,19221,132,2.11 [1.45-3.08],0.0001108554492221
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CST3,Cystatin-C,22740,157,2.07 [1.29-3.32],0.0025256084317157
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CST7,Cystatin-F,22745,156,1.18 [1.04-1.32],0.007602511878918
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSTB,Cystatin-B,22399,157,1.47 [1.06-2.03],0.0200033093615542
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTRL,Chymotrypsin-like protease CTRL-1,19732,135,1.31 [1.02-1.67],0.0328788139407388
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSL,Cathepsin L1,22711,157,2.18 [1.25-3.79],0.0059194936136768
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSO,Cathepsin O,22959,157,1.97 [1.28-3.05],0.0022164699206695
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSS,Cathepsin S,17832,122,3.51 [1.86-6.63],0.0001032058659124
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSV,Cathepsin L2,22851,156,0.67 [0.47-0.95],0.0226598482809899
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSZ,Cathepsin Z,22694,157,2.09 [1.35-3.24],0.0009384802148782
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CWC15,Spliceosome-associated protein CWC15 homolog,19552,133,1.32 [1.08-1.62],0.0074678905989617
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXADR,Coxsackievirus and adenovirus receptor,22671,156,1.28 [1.00-1.64],0.0479932961098687
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL10,C-X-C motif chemokine 10,22813,156,1.25 [1.04-1.50],0.0178183392875675
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL11,C-X-C motif chemokine 11,22906,153,1.32 [1.14-1.52],0.0002649232364371
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL13,C-X-C motif chemokine 13,22906,153,1.73 [1.60-1.87],4.5715285331478943e-41
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL16,C-X-C motif chemokine 16,22944,159,0.48 [0.26-0.88],0.0170910517542603
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL17,C-X-C motif chemokine 17,22959,157,1.40 [1.01-1.94],0.0408397946519509
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL9,C-X-C motif chemokine 9,22813,156,1.69 [1.44-1.97],3.5614445654897296e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CYB5R2,NADH-cytochrome b5 reductase 2,19428,133,1.41 [1.08-1.84],0.0112401576085742
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DBN1,Drebrin,19221,132,1.41 [1.05-1.89],0.0218998616368858
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCTN6,Dynactin subunit 6,22146,152,1.22 [1.03-1.45],0.0222253226423138
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCTPP1,dCTP pyrophosphatase 1,22711,157,3.04 [2.01-4.57],1.087744975805477e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCUN1D1,DCN1-like protein 1,19162,131,1.24 [1.04-1.47],0.0190137338187182
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDX58,Antiviral innate immune response receptor RIG-I,22194,151,1.28 [1.04-1.58],0.018573249768672
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DEFA1_DEFA1B,Neutrophil defensin 1,22230,155,1.36 [1.08-1.70],0.008251775690994
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DEFB103A_DEFB103B,Beta-defensin 103,19069,132,1.33 [1.01-1.76],0.0443236900813484
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DGCR6,Protein DGCR6,19162,131,1.33 [1.02-1.72],0.0337352080248462
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DGKZ,Diacylglycerol kinase zeta,22280,152,1.53 [1.05-2.23],0.0265447232148258
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DHODH,Dihydroorotate dehydrogenase,19168,129,1.38 [1.08-1.76],0.0095252094248179
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DKK1,Dickkopf-related protein 1,22906,153,1.38 [1.09-1.76],0.0080082897573628
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DLL1,Delta-like protein 1,22777,154,3.36 [2.19-5.17],3.4473913185789884e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJB8,DnaJ homolog subfamily B member 8,22305,153,1.24 [1.02-1.51],0.0285829374264368
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJC21,DnaJ homolog subfamily C member 21,19732,135,1.87 [1.33-2.64],0.0003027632676552
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJC6,Putative tyrosine-protein phosphatase auxilin,19267,128,1.25 [1.03-1.53],0.0253999005240773
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJC9,DnaJ homolog subfamily C member 9,19671,134,1.26 [1.02-1.56],0.0313657105653754
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNER,Delta and Notch-like epidermal growth factor-related receptor,22671,155,0.41 [0.23-0.72],0.0022162813620826
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DPP4,Dipeptidyl peptidase 4,22265,157,0.52 [0.32-0.83],0.0062672376452167
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DPY30,Protein dpy-30 homolog,22837,156,1.33 [1.08-1.64],0.0074427879939782
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DRAXIN,Draxin,22558,153,1.49 [1.08-2.06],0.0153805633021612
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DSC2,Desmocollin-2,22471,154,2.41 [1.73-3.36],1.962850975283295e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DTYMK,Thymidylate kinase,19770,134,1.28 [1.01-1.62],0.0396462469224681
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DXO,Decapping and exoribonuclease protein,19732,135,1.69 [1.20-2.36],0.0023860765379868
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EBI3_IL27,Interleukin-27,22871,156,2.41 [1.65-3.53],6.033024159810514e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ECHS1,"Enoyl-CoA hydratase, mitochondrial",19267,128,1.29 [1.09-1.52],0.0032360707685036
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ECI2,Enoyl-CoA delta isomerase 2,19168,129,1.33 [1.06-1.67],0.0153762166379485
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDA2R,Tumor necrosis factor receptor superfamily member 27,22910,156,2.14 [1.49-3.07],3.942900799773605e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDF1,Endothelial differentiation-related factor 1,19741,135,1.24 [1.03-1.50],0.0236139645759761
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDNRB,Endothelin receptor type B,19221,132,1.51 [1.19-1.91],0.0006019016309772
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFCAB14,EF-hand calcium-binding domain-containing protein 14,19671,134,1.71 [1.08-2.72],0.0222258820139613
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFCAB2,Dynein regulatory complex protein 8,19390,131,1.55 [1.04-2.33],0.0325101086577401
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFNA1,Ephrin-A1,22681,153,1.70 [1.02-2.82],0.0413272051642437
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFNA4,Ephrin-A4,22523,153,3.29 [2.19-4.93],8.905146348838141e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EGFL7,Epidermal growth factor-like protein 7,22194,151,1.68 [1.26-2.25],0.0004866110449899
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EGFR,Epidermal growth factor receptor,22983,159,0.45 [0.24-0.86],0.0156659622692198
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EGLN1,Egl nine homolog 1,22671,156,1.30 [1.08-1.57],0.0065074075556508
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,19267,128,1.44 [1.02-2.04],0.0385884407134135
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,22711,157,1.27 [1.04-1.56],0.0209848664398281
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ELAC1,Zinc phosphodiesterase ELAC protein 1,19741,135,1.27 [1.05-1.55],0.0159782652115478
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ELOA,Elongin-A,22605,154,1.29 [1.05-1.58],0.0169089573808943
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENAH,Protein enabled homolog,22280,152,1.35 [1.02-1.78],0.0347893520743245
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENDOU,Poly(U)-specific endoribonuclease,18259,123,0.62 [0.43-0.90],0.011174193617869
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENG,Endoglin,22983,159,2.25 [1.00-5.07],0.0494342316842274
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,19168,129,1.69 [1.04-2.74],0.0327266363312327
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,22305,153,2.38 [1.17-4.83],0.0166124471688848
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EP300,Histone acetyltransferase p300,19221,132,1.45 [1.00-2.10],0.049576465405872
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHA1,Ephrin type-A receptor 1,22779,156,1.62 [1.06-2.47],0.0262840722561749
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,21898,148,2.26 [1.68-3.06],9.898143981931417e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHB4,Ephrin type-B receptor 4,22983,159,2.14 [1.25-3.65],0.0053778779000268
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHB6,Ephrin type-B receptor 6,22510,153,2.64 [1.70-4.11],1.6923761709182674e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPO,Erythropoietin,22671,156,1.24 [1.06-1.45],0.0075972731070102
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPPK1,Epiplakin,19267,128,1.34 [1.08-1.65],0.0077805030433857
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERI1,3'-5' exoribonuclease 1,19390,131,1.65 [1.10-2.49],0.0160957050255271
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERMAP,Erythroid membrane-associated protein,19221,132,1.64 [1.16-2.34],0.005792501059699
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ESAM,Endothelial cell-selective adhesion molecule,22983,159,2.21 [1.46-3.34],0.0001777064052415
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ESR1,Estrogen receptor,19221,132,1.34 [1.10-1.65],0.0042161103509004
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ESYT2,Extended synaptotagmin-2,19732,135,1.21 [1.00-1.48],0.0493412676263253
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EZR,Ezrin,22906,153,1.99 [1.13-3.50],0.0166244332663443
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",F3,Tissue factor,22775,156,1.71 [1.05-2.78],0.0314354024973972
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FABP1,"Fatty acid-binding protein, liver",22704,156,1.18 [1.02-1.37],0.0265053246501739
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FABP6,Gastrotropin,22272,153,1.28 [1.01-1.63],0.040054912540056
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAM171B,Protein FAM171B,19665,134,1.75 [1.16-2.65],0.0081241877764285
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAM3C,Protein FAM3C,22677,157,1.60 [1.00-2.57],0.0490353271866454
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAP,Prolyl endopeptidase FAP,22983,159,0.51 [0.31-0.85],0.0095530367836373
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAS,Tumor necrosis factor receptor superfamily member 6,22915,159,1.51 [1.14-2.00],0.0038826758761854
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,19770,134,2.48 [2.08-2.95],4.638014545014571e-24
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCER2,Low affinity immunoglobulin epsilon Fc receptor,22717,155,3.16 [2.51-3.97],8.105452405430154e-23
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL1,Fc receptor-like protein 1,22711,157,3.17 [2.35-4.28],4.207306484720868e-14
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL2,Fc receptor-like protein 2,22851,156,3.37 [2.87-3.97],1.123195147390832e-48
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL3,Fc receptor-like protein 3,22280,152,2.17 [1.70-2.76],3.5283833827443165e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL5,Fc receptor-like protein 5,22717,155,1.35 [1.05-1.74],0.0187194536345068
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL6,Fc receptor-like protein 6,22671,156,1.27 [1.03-1.56],0.0274994846521686
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRLB,Fc receptor-like B,22194,151,1.55 [1.31-1.83],3.3520612003224925e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FDX2,"Ferredoxin-2, mitochondrial",19168,129,1.29 [1.01-1.64],0.037612833709805
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF16,Fibroblast growth factor 16,19221,132,1.30 [1.00-1.69],0.049904854727002
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF2,Fibroblast growth factor 2,22671,156,1.37 [1.12-1.68],0.001988615647984
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF23,Fibroblast growth factor 23,22878,156,1.24 [1.01-1.52],0.0418963667599258
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGFBP1,Fibroblast growth factor-binding protein 1,22777,154,0.60 [0.39-0.94],0.0247889645195989
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGFBP2,Fibroblast growth factor-binding protein 2,19766,134,0.46 [0.33-0.65],1.2569226136629051e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,19741,135,1.19 [1.01-1.41],0.0415379750391755
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,22558,153,1.45 [1.05-1.99],0.0247812572906192
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,22098,152,1.40 [1.11-1.75],0.0040912549520364
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,22558,153,2.02 [1.24-3.29],0.0046488826629166
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FLT3LG,Fms-related tyrosine kinase 3 ligand,22959,157,1.76 [1.15-2.71],0.0098516211459201
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FLT4,Vascular endothelial growth factor receptor 3,22777,154,1.73 [1.11-2.70],0.0153659167498167
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,19665,134,1.56 [1.07-2.26],0.0204521630675702
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOLH1,Glutamate carboxypeptidase 2,19221,132,1.14 [1.01-1.29],0.0323118247885021
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOLR1,Folate receptor alpha,22669,153,2.07 [1.28-3.35],0.0031480809584814
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOSB,Protein fosB,22146,152,1.33 [1.01-1.75],0.0452141408542128
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOXO1,Forkhead box protein O1,22671,156,1.19 [1.01-1.40],0.04214327394589
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOXO3,Forkhead box protein O3,22194,151,1.25 [1.10-1.43],0.0006531742363733
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FSHB,Follitropin subunit beta,19267,128,1.43 [1.11-1.84],0.006286933171283
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FST,Follistatin,22774,156,0.68 [0.50-0.91],0.0086614158975451
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FSTL1,Follistatin-related protein 1,19267,128,2.81 [1.63-4.87],0.0002173414096892
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FUS,RNA-binding protein FUS,22163,151,1.73 [1.28-2.34],0.0003587408317245
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FUT8,"Alpha-(1,6)-fucosyltransferase",22558,153,1.33 [1.05-1.69],0.0162969979972444
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FZD8,Frizzled-8,19162,131,1.43 [1.09-1.86],0.009253804509775
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GABARAP,Gamma-aminobutyric acid receptor-associated protein,19665,134,1.36 [1.04-1.76],0.0233516632138273
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,19390,131,1.30 [1.08-1.56],0.0063503769185545
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GAL,Galanin peptides,22813,156,0.61 [0.48-0.77],4.082055309716273e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,22605,154,2.02 [1.24-3.30],0.0050563699650242
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GAS2,Growth arrest-specific protein 2,19390,131,1.30 [1.04-1.63],0.0212452120763395
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GASK1A,Golgi-associated kinase 1A,19168,129,0.64 [0.43-0.94],0.0245562385781675
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GBP1,Guanylate-binding protein 1,19695,135,1.47 [1.18-1.83],0.000630072917237
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GBP2,Guanylate-binding protein 2,22280,152,1.31 [1.05-1.63],0.0157521553042301
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,18888,129,1.46 [1.13-1.89],0.0037132953684735
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GCLM,Glutamate--cysteine ligase regulatory subunit,19168,129,1.39 [1.08-1.79],0.0111483434887238
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",22605,154,2.54 [1.76-3.68],7.691282664649009e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GDF15,Growth/differentiation factor 15,22983,159,1.66 [1.32-2.10],2.018376264616561e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GFRA1,GDNF family receptor alpha-1,22871,156,2.14 [1.31-3.47],0.0021951844783214
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GHRL,Appetite-regulating hormone,22711,157,0.84 [0.70-0.99],0.0413497317784474
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GIPC2,PDZ domain-containing protein GIPC2,19732,135,1.72 [1.02-2.89],0.0425913623239154
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GKN1,Gastrokine-1,21719,150,2.11 [1.33-3.33],0.0014410867943312
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLI2,Zinc finger protein GLI2,19221,132,1.67 [1.19-2.33],0.0026639149295055
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLRX,Glutaredoxin-1,22560,156,1.48 [1.17-1.86],0.0009016618467114
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",19358,132,1.23 [1.02-1.47],0.0266545413241785
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GM2A,Ganglioside GM2 activator,19291,133,1.54 [1.21-1.96],0.0004960342098876
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GOLGA3,Golgin subfamily A member 3,19741,135,1.28 [1.05-1.56],0.0138350379172177
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GOLM2,Protein GOLM2,22906,153,2.14 [1.21-3.78],0.0088978187159363
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPKOW,G-patch domain and KOW motifs-containing protein,22146,152,1.52 [1.06-2.19],0.0240162955083209
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,19770,134,1.30 [1.01-1.67],0.044141421519827
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRN,Progranulin,22617,152,3.23 [1.89-5.52],1.8179241562054905e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRPEL1,"GrpE protein homolog 1, mitochondrial",22605,154,1.36 [1.10-1.68],0.0042368765382915
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRSF1,G-rich sequence factor 1,18967,128,1.26 [1.04-1.52],0.020896773891638
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GZMA,Granzyme A,22959,157,2.08 [1.55-2.80],1.135526335220208e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GZMH,Granzyme H,22305,153,1.26 [1.08-1.46],0.0026768930191316
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,22717,155,1.84 [1.26-2.70],0.0017460161405758
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HDAC8,Histone deacetylase 8,19221,132,1.31 [1.09-1.58],0.0044662923157813
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HDDC2,5'-deoxynucleotidase HDDC2,19671,134,1.64 [1.18-2.27],0.0028865151717257
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HDGFL2,Hepatoma-derived growth factor-related protein 2,19732,135,1.35 [1.07-1.70],0.0114235120710763
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HGF,Hepatocyte growth factor,22959,157,1.68 [1.13-2.49],0.0095756179422142
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HGFAC,Hepatocyte growth factor activator,19581,134,0.68 [0.47-0.98],0.0407742957302303
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HHEX,Hematopoietically-expressed homeobox protein HHEX,19732,135,1.28 [1.04-1.58],0.0226722100688473
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HIP1R,Huntingtin-interacting protein 1-related protein,19697,135,1.63 [1.27-2.10],0.0001359058317721
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",19741,135,2.00 [1.20-3.36],0.0083003544878676
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",22605,156,1.68 [1.17-2.40],0.0047438240484088
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",22671,156,3.18 [2.17-4.66],2.9938005700371623e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",19267,128,1.55 [1.17-2.06],0.0023557270423577
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HNMT,Histamine N-methyltransferase,22440,153,1.53 [1.14-2.05],0.0049101958863146
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,19741,135,1.67 [1.32-2.10],1.339313320293716e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HPSE,Heparanase,19489,134,1.33 [1.11-1.60],0.0020610172059353
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HS1BP3,HCLS1-binding protein 3,19267,128,1.24 [1.03-1.50],0.0260557392422512
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,22910,156,1.74 [1.25-2.43],0.0010510506826992
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,19267,128,1.61 [1.17-2.21],0.0032682706765545
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSPA2,Heat shock-related 70 kDa protein 2,19665,134,1.67 [1.17-2.38],0.0049671438267947
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HTR1A,5-hydroxytryptamine receptor 1A,19162,131,1.18 [1.01-1.39],0.0417150124506268
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HTR1B,5-hydroxytryptamine receptor 1B,19162,131,1.45 [1.09-1.93],0.0106367921616735
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,22595,157,2.11 [1.34-3.32],0.0012525445718324
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ICAM2,Intercellular adhesion molecule 2,22983,159,2.24 [1.41-3.53],0.000569105062746
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ICAM3,Intercellular adhesion molecule 3,22983,159,5.66 [3.45-9.30],7.069191296429736e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,19186,130,2.12 [1.50-3.01],2.2602451983347825e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,19390,131,1.48 [1.02-2.14],0.0379864161306051
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNGR1,Interferon gamma receptor 1,22813,156,2.91 [1.49-5.69],0.0017719803911448
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNL1,Interferon lambda-1,22146,152,1.48 [1.11-1.96],0.0067902569716966
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNLR1,Interferon lambda receptor 1,22671,156,2.01 [1.64-2.48],2.8213286563134608e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGBP1,Immunoglobulin-binding protein 1,19741,135,1.35 [1.05-1.74],0.0208224916764095
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,19766,134,0.37 [0.20-0.70],0.0019322420207259
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFBP2,Insulin-like growth factor-binding protein 2,22944,159,1.46 [1.16-1.84],0.0011262935572911
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFBP4,Insulin-like growth factor-binding protein 4,22420,153,1.68 [1.23-2.27],0.0009459334368163
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGSF8,Immunoglobulin superfamily member 8,22711,157,1.63 [1.03-2.57],0.0356221647433166
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGSF9,Protein turtle homolog A,19770,134,0.78 [0.63-0.96],0.0215420092056243
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL10,Interleukin-10,22280,152,1.47 [1.34-1.62],4.486341719628568e-16
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL10RB,Interleukin-10 receptor subunit beta,22813,156,2.06 [1.37-3.08],0.000484050121096
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL12A_IL12B,Interleukin-12,22605,154,1.58 [1.35-1.86],1.6383682220305098e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL12B,Interleukin-12 subunit beta,22959,157,1.92 [1.50-2.46],2.495201773935231e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL12RB1,Interleukin-12 receptor subunit beta-1,22280,152,2.30 [1.69-3.13],1.3054364489142818e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL15RA,Interleukin-15 receptor subunit alpha,22280,152,2.00 [1.34-3.00],0.000762922006001
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL17RB,Interleukin-17 receptor B,22378,156,1.80 [1.38-2.35],1.2310170723806171e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL18,Interleukin-18,22628,155,1.78 [1.39-2.28],4.488104117062065e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,22773,157,2.69 [1.87-3.88],1.2037506246561372e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL18R1,Interleukin-18 receptor 1,22959,157,1.82 [1.21-2.74],0.0042762304148923
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL19,Interleukin-19,22142,152,1.31 [1.08-1.59],0.0056068280119237
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL1B,Interleukin-1 beta,22176,149,1.34 [1.08-1.66],0.0080815393430891
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL1R1,Interleukin-1 receptor type 1,22681,153,2.53 [1.41-4.55],0.0019198338760334
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL1R2,Interleukin-1 receptor type 2,22675,156,0.45 [0.23-0.92],0.0272554366290754
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL20,Interleukin-20,22280,152,1.24 [1.01-1.52],0.0430389469186552
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL22,Interleukin-22,19665,134,1.26 [1.02-1.57],0.031948498565029
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL25,Interleukin-25,19003,128,0.62 [0.38-1.00],0.0486335972563557
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,22541,157,3.81 [2.89-5.02],2.104819366169093e-21
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL2RG,Cytokine receptor common subunit gamma,19665,134,1.48 [1.13-1.94],0.0047246373478114
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL3RA,Interleukin-3 receptor subunit alpha,22280,152,2.14 [1.47-3.12],7.669062681690472e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL4R,Interleukin-4 receptor subunit alpha,22671,156,2.54 [1.92-3.36],8.330547484940007e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL6,Interleukin-6,22605,154,1.29 [1.12-1.48],0.0004280098939495
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,22121,152,1.39 [1.12-1.73],0.0025556661174662
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IMMT,MICOS complex subunit MIC60,19665,134,1.80 [1.43-2.26],4.100696996213981e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IMPACT,Protein IMPACT,19732,135,1.54 [1.16-2.04],0.0027169114942231
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ING1,Inhibitor of growth protein 1,22098,152,1.38 [1.08-1.77],0.010721629528096
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INPP1,Inositol polyphosphate 1-phosphatase,22605,154,1.33 [1.04-1.72],0.0254716190709067
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",19267,128,1.39 [1.04-1.85],0.0245119013300439
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INSL3,Insulin-like 3,19732,135,0.76 [0.60-0.97],0.024656213238426
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGA2,Integrin alpha-2,19358,132,0.54 [0.33-0.88],0.0135052076621243
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGAX,Integrin alpha-X,19390,131,1.31 [1.02-1.68],0.0360487311774214
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGB7,Integrin beta-7,22910,156,1.53 [1.15-2.02],0.0033043674132437
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITM2A,Integral membrane protein 2A,22671,156,1.66 [1.32-2.08],1.21473046809558e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITPA,Inosine triphosphate pyrophosphatase,19168,129,1.37 [1.08-1.73],0.0089154416908613
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",22146,152,1.39 [1.09-1.76],0.0079138674751763
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",JAM3,Junctional adhesion molecule C,19358,132,1.41 [1.04-1.90],0.0255338382252615
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",JCHAIN,Immunoglobulin J chain,22280,152,1.96 [1.62-2.37],2.993691691001677e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KCTD5,BTB/POZ domain-containing protein KCTD5,19368,133,1.49 [1.11-2.01],0.0086134001452908
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KDM3A,Lysine-specific demethylase 3A,19221,132,1.18 [1.03-1.36],0.0184054921987154
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KHK,Ketohexokinase,19267,128,1.48 [1.13-1.93],0.0038822938510089
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIF1C,Kinesin-like protein KIF1C,19168,129,1.51 [1.10-2.08],0.0117911926201642
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,19665,134,1.26 [1.05-1.52],0.0138888970821903
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,22194,151,1.25 [1.04-1.49],0.0157673148065692
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIRREL2,Kin of IRRE-like protein 2,22146,152,1.78 [1.36-2.31],1.9488176971867872e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK11,Kallikrein-11,22554,154,1.58 [1.08-2.32],0.0180019428517575
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLRB1,Killer cell lectin-like receptor subfamily B member 1,22959,157,2.38 [1.68-3.38],1.1408454379651677e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLRD1,Natural killer cells antigen CD94,22959,157,1.59 [1.18-2.15],0.0025757268329356
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLRK1,NKG2-D type II integral membrane protein,19732,135,1.74 [1.27-2.39],0.000571426826065
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KRT18,"Keratin, type I cytoskeletal 18",22605,154,1.22 [1.03-1.45],0.0200403550915392
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KRT19,"Keratin, type I cytoskeletal 19",22638,156,1.51 [1.26-1.81],9.629901247902778e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",L1CAM,Neural cell adhesion molecule L1,22777,154,1.82 [1.11-2.99],0.0170769389026191
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAG3,Lymphocyte activation gene 3 protein,22605,154,2.41 [1.91-3.04],8.34602046764439e-14
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,22704,156,1.95 [1.45-2.62],9.691697226806696e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,22558,153,1.24 [1.07-1.44],0.0044875271218809
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAMP3,Lysosome-associated membrane glycoprotein 3,22918,156,1.64 [1.25-2.13],0.0002880030662066
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAMTOR5,Ragulator complex protein LAMTOR5,19665,134,1.39 [1.01-1.90],0.0403890593301699
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAYN,Layilin,22510,153,1.76 [1.19-2.61],0.0046347891808187
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LBP,Lipopolysaccharide-binding protein,22773,157,1.28 [1.01-1.62],0.0384757067122419
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LCN15,Lipocalin-15,19741,135,1.30 [1.05-1.59],0.0141183397574901
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LCN2,Neutrophil gelatinase-associated lipocalin,22004,153,1.62 [1.17-2.26],0.0041720840408819
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LETM1,Mitochondrial proton/calcium exchanger protein,19741,135,1.60 [1.24-2.08],0.0003657953376296
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGALS1,Galectin-1,22711,157,1.51 [1.01-2.25],0.0454959758507149
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGALS3BP,Galectin-3-binding protein,19799,134,1.71 [1.13-2.58],0.0112729473293898
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGALS4,Galectin-4,22704,156,1.48 [1.15-1.90],0.002174519870394
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,22706,156,2.45 [1.65-3.62],7.683707862994658e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGMN,Legumain,22813,156,1.69 [1.16-2.47],0.0060490703730958
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LHB,Lutropin subunit beta,22194,151,1.16 [1.00-1.35],0.0472821886898474
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LIF,Leukemia inhibitory factor,22146,152,1.27 [1.03-1.55],0.0248418982486411
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LIFR,Leukemia inhibitory factor receptor,22671,156,2.23 [1.33-3.73],0.0022355898159341
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,22717,155,1.59 [1.05-2.42],0.0291214912292483
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,19168,129,1.52 [1.23-1.89],0.0001045814160803
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,22677,157,2.14 [1.37-3.33],0.0007785628259126
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,22983,159,3.03 [1.82-5.03],1.9731513956060776e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,22876,159,1.93 [1.26-2.95],0.0023409681925092
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,22280,152,2.15 [1.59-2.90],5.875445042945784e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LMNB2,Lamin-B2,19732,135,2.96 [1.96-4.46],2.2992862279908577e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LONP1,"Lon protease homolog, mitochondrial",19267,128,1.32 [1.10-1.59],0.0033260511280216
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRG1,Leucine-rich alpha-2-glycoprotein,19799,134,3.03 [1.82-5.05],2.186075226339429e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,22838,156,2.35 [1.59-3.47],1.6830074649613195e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRP1,Prolow-density lipoprotein receptor-related protein 1,22605,154,1.88 [1.13-3.12],0.0150142557821233
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRRC25,Leucine-rich repeat-containing protein 25,22605,154,1.67 [1.22-2.27],0.0012762433799426
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTA,Lymphotoxin-alpha,22671,156,2.16 [1.77-2.64],4.877804724999357e-14
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTBP2,Latent-transforming growth factor beta-binding protein 2,22983,159,2.00 [1.31-3.05],0.0012918781111966
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTBP3,Latent-transforming growth factor beta-binding protein 3,22194,151,1.40 [1.14-1.71],0.0011824775304139
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTBR,Tumor necrosis factor receptor superfamily member 3,22602,156,2.19 [1.37-3.51],0.0010675358256433
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LY75,Lymphocyte antigen 75,22671,156,1.74 [1.19-2.56],0.0045671054211374
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LY9,T-lymphocyte surface antigen Ly-9,22489,153,6.56 [4.29-10.02],3.5157639187400915e-18
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LY96,Lymphocyte antigen 96,22558,153,1.60 [1.11-2.28],0.0106225263269139
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYPD8,Ly6/PLAUR domain-containing protein 8,22194,151,1.68 [1.44-1.96],4.6137390164203766e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",M6PR,Cation-dependent mannose-6-phosphate receptor,19267,128,1.43 [1.05-1.94],0.0236152883771557
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,22474,153,1.51 [1.25-1.81],1.6676888054199175e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",19267,128,2.92 [1.50-5.67],0.0015996979302316
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,19671,134,1.32 [1.03-1.69],0.0298424963579732
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MARCO,Macrophage receptor MARCO,22711,157,3.36 [2.04-5.55],2.073524422826536e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MASP1,Mannan-binding lectin serine protease 1,22510,153,2.08 [1.12-3.86],0.0202534281833458
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MATN2,Matrilin-2,22746,156,2.39 [1.50-3.83],0.0002632211193877
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MB,Myoglobin,22983,159,1.31 [1.01-1.69],0.0424922793539833
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",19741,135,1.39 [1.04-1.87],0.0284425047236542
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MCFD2,Multiple coagulation factor deficiency protein 2,22612,155,1.41 [1.02-1.94],0.0384348822186492
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MDK,Midkine,22718,154,1.31 [1.04-1.65],0.0198720743284782
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",19267,128,1.26 [1.05-1.51],0.012688533535419
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MENT,Protein MENT,19358,132,0.35 [0.17-0.73],0.0051702335546059
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MILR1,Allergin-1,22280,152,1.51 [1.15-1.99],0.0027964482786858
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MKI67,Proliferation marker protein Ki-67,19221,132,1.44 [1.07-1.94],0.0158209926301409
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP1,Interstitial collagenase,21837,148,1.32 [1.11-1.55],0.0013164263206686
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP12,Macrophage metalloelastase,22730,156,1.98 [1.55-2.53],5.213131946927677e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MN1,Transcriptional activator MN1,19219,128,1.30 [1.04-1.62],0.0218933241436534
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MPO,Myeloperoxidase,22717,155,1.32 [1.00-1.74],0.0484038384100829
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MRPL46,"39S ribosomal protein L46, mitochondrial",22146,152,1.81 [1.20-2.71],0.0043124452139769
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MST1,Hepatocyte growth factor-like protein,19461,133,0.82 [0.68-0.99],0.0341664640517345
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MTDH,Protein LYRIC,19221,132,1.26 [1.06-1.51],0.0104759248536643
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",19732,135,1.97 [1.27-3.06],0.0025422681607748
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MVK,Mevalonate kinase,22280,152,1.20 [1.01-1.43],0.0428150560136386
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYBPC1,"Myosin-binding protein C, slow-type",19770,134,1.30 [1.03-1.63],0.0273342509205897
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYBPC2,"Myosin-binding protein C, fast-type",19267,128,1.23 [1.06-1.43],0.0081373315766605
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYL4,Myosin light chain 4,19267,128,1.32 [1.01-1.72],0.0446499059473816
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MZB1,Marginal zone B- and B1-cell-specific protein,22785,156,1.43 [1.10-1.85],0.0066532842658435
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAA10,N-alpha-acetyltransferase 10,19168,129,1.40 [1.01-1.93],0.0413600184933897
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAGA,Alpha-N-acetylgalactosaminidase,19182,132,1.38 [1.14-1.67],0.0010800091987602
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAMPT,Nicotinamide phosphoribosyltransferase,22194,151,1.28 [1.05-1.56],0.0159800049162922
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAPRT,Nicotinate phosphoribosyltransferase,19732,135,1.66 [1.16-2.38],0.0053200166625795
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NBL1,Neuroblastoma suppressor of tumorigenicity 1,22777,154,2.12 [1.26-3.56],0.0047304829681386
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCAM1,Neural cell adhesion molecule 1,22773,157,0.55 [0.33-0.91],0.0204159292421098
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCLN,Nicalin,22280,152,1.26 [1.04-1.54],0.0185214268745073
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCR1,Natural cytotoxicity triggering receptor 1,22636,154,1.80 [1.22-2.65],0.0028097665175806
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCS1,Neuronal calcium sensor 1,22910,156,2.12 [1.29-3.47],0.0028885012714842
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NDRG1,Protein NDRG1,22146,152,1.24 [1.07-1.44],0.0050042801664551
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",22194,151,1.19 [1.03-1.37],0.0203875664411888
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NECAP2,Adaptin ear-binding coat-associated protein 2,19168,129,1.26 [1.01-1.56],0.0412196726218042
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NECTIN2,Nectin-2,22677,157,2.66 [1.70-4.16],1.729684432791157e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NECTIN4,Nectin-4,22777,154,1.64 [1.06-2.54],0.0253001008109877
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NEDD9,Enhancer of filamentation 1,19221,132,1.58 [1.10-2.27],0.0135937479318632
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFKBIE,NF-kappa-B inhibitor epsilon,22194,151,1.54 [1.19-2.00],0.0009764036206153
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NHLRC3,NHL repeat-containing protein 3,18877,130,2.31 [1.33-4.02],0.0028556139993587
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NIT1,Deaminated glutathione amidase,19267,128,1.47 [1.01-2.12],0.0431850044008525
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NIT2,Omega-amidase NIT2,19699,132,1.28 [1.02-1.60],0.0297170036481875
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NMI,N-myc-interactor,19594,134,1.39 [1.13-1.70],0.0016680824834267
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,19741,135,1.24 [1.02-1.51],0.0274304447496104
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOS1,"Nitric oxide synthase, brain",22146,152,1.57 [1.19-2.06],0.0012337637837566
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOS3,"Nitric oxide synthase, endothelial",22146,152,2.12 [1.89-2.37],9.437788181969877e-40
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOTCH1,Neurogenic locus notch homolog protein 1,22983,159,3.18 [1.35-7.53],0.0083552574978847
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPC2,NPC intracellular cholesterol transporter 2,19431,134,2.20 [1.61-3.03],1.0070556525467351e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPDC1,Neural proliferation differentiation and control protein 1,22711,157,1.71 [1.12-2.60],0.0124364593601577
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPHS1,Nephrin,19221,132,1.65 [1.10-2.46],0.0153669751609473
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPPC,C-type natriuretic peptide,22671,156,1.81 [1.36-2.41],5.3366986623271495e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPTX2,Neuronal pentraxin-2,19766,134,0.51 [0.31-0.85],0.0102973036507971
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NRCAM,Neuronal cell adhesion molecule,22711,157,2.28 [1.44-3.59],0.0004003210150641
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NRP2,Neuropilin-2,22717,155,1.91 [1.23-2.97],0.0039333510671339
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NT5C1A,Cytosolic 5'-nucleotidase 1A,19732,135,1.76 [1.29-2.40],0.0003772056666895
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NTRK2,BDNF/NT-3 growth factors receptor,22711,157,0.57 [0.33-0.99],0.0453730834220725
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUB1,NEDD8 ultimate buster 1,22671,156,1.19 [1.01-1.39],0.0385949782334988
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUCB2,Nucleobindin-2,22869,156,1.54 [1.07-2.23],0.0216403448245816
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUP50,Nuclear pore complex protein Nup50,19168,129,1.57 [1.14-2.15],0.0058261257223349
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OCLN,Occludin,19741,135,1.89 [1.37-2.60],0.0001160650870939
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OFD1,Oral-facial-digital syndrome 1 protein,19390,131,1.26 [1.04-1.53],0.0186079660687987
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OGFR,Opioid growth factor receptor,22605,154,1.74 [1.16-2.63],0.0080944946741886
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OGN,Mimecan,22717,155,1.58 [1.13-2.21],0.0071465956794023
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OPLAH,5-oxoprolinase,19267,128,1.41 [1.12-1.78],0.0036179827984079
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ORM1,Alpha-1-acid glycoprotein 1,19731,134,3.43 [1.65-7.14],0.0009380156610347
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OSCAR,Osteoclast-associated immunoglobulin-like receptor,22746,156,2.82 [1.85-4.32],1.6715526000790729e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OTUD6B,Deubiquitinase OTUD6B,19671,134,1.43 [1.09-1.87],0.0105737801558192
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",19267,128,1.57 [1.24-1.98],0.0001539915987288
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OXT,Oxytocin-neurophysin 1,22906,153,0.84 [0.75-0.94],0.0027376104214958
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PACS2,Phosphofurin acidic cluster sorting protein 2,19168,129,1.41 [1.09-1.82],0.0095840657831421
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PADI2,Protein-arginine deiminase type-2,22280,152,1.23 [1.01-1.49],0.0362625917995068
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAGR1,PAXIP1-associated glutamate-rich protein 1,19267,128,1.59 [1.20-2.11],0.0013648814960081
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PARP1,Poly [ADP-ribose] polymerase 1,22671,156,1.28 [1.07-1.53],0.0064259234522799
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAXX,Protein PAXX,19358,132,1.47 [1.05-2.05],0.0260628318799562
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCDH1,Protocadherin-1,22888,156,1.79 [1.08-2.99],0.0247680940905881
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCDH17,Protocadherin-17,22711,157,1.78 [1.21-2.62],0.0035764473356423
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDCD1,Programmed cell death protein 1,22877,155,3.43 [3.01-3.90],6.630597252985613e-78
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDCD1LG2,Programmed cell death 1 ligand 2,22605,154,2.22 [1.45-3.39],0.0002404679582585
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",19168,129,1.24 [1.00-1.54],0.0481964270148755
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDGFA,Platelet-derived growth factor subunit A,22983,159,1.24 [1.02-1.51],0.0281437019896188
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",22194,151,1.26 [1.01-1.57],0.0394133924305362
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDZD2,PDZ domain-containing protein 2,19168,129,1.39 [1.10-1.74],0.0051852953632198
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,19221,132,1.51 [1.11-2.06],0.008781305172728
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PECR,Peroxisomal trans-2-enoyl-CoA reductase,19267,128,1.83 [1.33-2.51],0.0001746087177396
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PEPD,Xaa-Pro dipeptidase,19775,135,0.49 [0.27-0.90],0.0208543330237936
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PER3,Period circadian protein homolog 3,19221,132,1.18 [1.03-1.35],0.0142599562106238
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PF4,Platelet factor 4,19656,132,1.19 [1.01-1.40],0.0379647004235726
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",19770,134,1.36 [1.02-1.82],0.0359659426835341
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGF,Placenta growth factor,22959,157,2.34 [1.73-3.15],2.5498998908927466e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGM2,Phosphoglucomutase-2,19219,128,1.32 [1.09-1.61],0.0055879571912404
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGR,Progesterone receptor,19221,132,1.16 [1.02-1.32],0.0203617529014378
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,22558,153,1.95 [1.20-3.16],0.0070597012709933
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,22717,155,2.77 [1.73-4.42],2.114676659089144e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLA2G15,Phospholipase A2 group XV,22777,154,2.01 [1.18-3.43],0.009846104001842
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLAUR,Urokinase plasminogen activator surface receptor,22562,156,2.32 [1.40-3.84],0.0010964821415245
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLTP,Phospholipid transfer protein,22896,159,0.66 [0.45-0.98],0.0405222010494194
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLXNB2,Plexin-B2,22882,159,1.81 [1.01-3.23],0.0463117699201776
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PMCH,Pro-MCH,19168,129,1.16 [1.00-1.35],0.0487349400287634
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PMM2,Phosphomannomutase 2,19168,129,1.42 [1.09-1.86],0.0097673089883283
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PNMA1,Paraneoplastic antigen Ma1,19267,128,1.55 [1.18-2.03],0.0016782654373512
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",POF1B,Protein POF1B,19221,132,1.56 [1.17-2.09],0.0027100204943264
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",22605,154,1.65 [1.25-2.17],0.0003880925488126
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPBP,Platelet basic protein,19652,132,1.27 [1.04-1.54],0.0169964256263848
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPM1A,Protein phosphatase 1A,22194,151,1.47 [1.02-2.13],0.0379111341962123
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPME1,Protein phosphatase methylesterase 1,22605,154,1.28 [1.01-1.61],0.0373467126262537
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,19741,135,1.54 [1.10-2.17],0.0126678789121272
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRAP1,Proline-rich acidic protein 1,19766,134,1.75 [1.17-2.61],0.0068188630541348
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRKD2,Serine/threonine-protein kinase D2,19168,129,1.38 [1.09-1.76],0.0084860745739717
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,22194,151,1.27 [1.03-1.56],0.02338379567815
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRTN3,Myeloblastin,22123,155,1.39 [1.09-1.79],0.0093527769204798
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSAP,Prosaposin,19576,134,2.12 [1.50-3.01],2.1008250936125763e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSIP1,PC4 and SFRS1-interacting protein,22671,156,1.24 [1.04-1.49],0.0183334615465021
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSMD1,26S proteasome non-ATPase regulatory subunit 1,19741,135,1.44 [1.08-1.93],0.0144787766725755
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSME1,Proteasome activator complex subunit 1,22528,153,1.53 [1.06-2.21],0.0219304267268877
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSME2,Proteasome activator complex subunit 2,22446,153,2.03 [1.41-2.93],0.0001422600117268
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSMG3,Proteasome assembly chaperone 3,22671,156,1.54 [1.19-1.98],0.000891736680535
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSMG4,Proteasome assembly chaperone 4,19221,132,1.40 [1.08-1.79],0.0095408281058972
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTGDS,Prostaglandin-H2 D-isomerase,22514,157,2.30 [1.58-3.36],1.5803943014986443e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,22671,156,1.38 [1.09-1.76],0.0081448618291075
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTK7,Inactive tyrosine-protein kinase 7,22146,152,1.55 [1.07-2.23],0.0193726548476752
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTN,Pleiotrophin,22305,153,1.67 [1.28-2.18],0.0001524157636988
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRB,Receptor-type tyrosine-protein phosphatase beta,19770,134,0.53 [0.29-0.94],0.0305544837848845
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRC,Receptor-type tyrosine-protein phosphatase C,19766,134,5.56 [3.29-9.42],1.6961072731545883e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRM,Receptor-type tyrosine-protein phosphatase mu,22634,156,3.44 [1.97-6.01],1.4708692270271473e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTTG1,Securin,19390,131,1.36 [1.00-1.84],0.0493896149191589
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PXN,Paxillin,22146,152,1.33 [1.06-1.68],0.0140381550782011
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",QPCT,Glutaminyl-peptide cyclotransferase,22753,158,2.03 [1.25-3.31],0.0042194706941116
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB6A,Ras-related protein Rab-6A,22671,156,0.63 [0.46-0.85],0.003087718641963
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RABGAP1L,Rab GTPase-activating protein 1-like,22280,152,1.25 [1.00-1.57],0.0494494928851542
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RANBP1,Ran-specific GTPase-activating protein,19267,128,1.43 [1.06-1.92],0.0207995421990717
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RARRES1,Retinoic acid receptor responder protein 1,22194,151,1.41 [1.04-1.91],0.0287643578088425
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RASSF2,Ras association domain-containing protein 2,22194,151,1.28 [1.05-1.56],0.0130255712721465
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBFOX3,RNA binding protein fox-1 homolog 3,19741,135,1.83 [1.33-2.50],0.0001749494243403
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBKS,Ribokinase,22169,153,1.35 [1.03-1.77],0.0294477382653908
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBM17,Splicing factor 45,19741,135,1.25 [1.02-1.53],0.03391655375065
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBP5,Retinol-binding protein 5,22605,154,1.60 [1.30-1.98],1.2454939090951184e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RCC1,Regulator of chromosome condensation,19665,134,1.59 [1.32-1.92],8.235591661467731e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REEP4,Receptor expression-enhancing protein 4,19741,135,1.32 [1.04-1.67],0.0220339123143111
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REG1A,Lithostathine-1-alpha,22553,157,1.45 [1.14-1.86],0.0028821580510263
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REG1B,Lithostathine-1-beta,22983,159,1.34 [1.08-1.66],0.0071772857653548
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REG3A,Regenerating islet-derived protein 3-alpha,22983,159,1.51 [1.24-1.85],4.508604433651191e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REG4,Regenerating islet-derived protein 4,22746,156,1.39 [1.05-1.84],0.0201991008510304
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RELT,Tumor necrosis factor receptor superfamily member 19L,22717,155,3.28 [2.11-5.10],1.2896808182919493e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REN,Renin,22711,157,1.32 [1.11-1.56],0.0013255821928227
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RETN,Resistin,22645,158,1.47 [1.07-2.02],0.0181105906713074
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNASE6,Ribonuclease K6,19620,135,1.70 [1.23-2.35],0.0012480412965037
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNASET2,Ribonuclease T2,22883,159,2.55 [1.83-3.57],3.585564543461272e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNF149,E3 ubiquitin-protein ligase RNF149,19267,128,2.33 [1.72-3.18],6.920080578256678e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNF168,E3 ubiquitin-protein ligase RNF168,19221,132,1.50 [1.11-2.02],0.0091285858052995
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ROBO1,Roundabout homolog 1,22746,156,3.45 [2.18-5.47],1.3340368033289628e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RPA2,Replication protein A 32 kDa subunit,19221,132,1.58 [1.03-2.41],0.0340402980383227
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RPL14,60S ribosomal protein L14,19267,128,1.48 [1.07-2.06],0.0192765709488688
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RRM2,Ribonucleoside-diphosphate reductase subunit M2,22194,151,1.44 [1.23-1.70],9.688641385843207e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RSPO3,R-spondin-3,22910,156,2.22 [1.38-3.58],0.0009871234459125
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",S100A13,Protein S100-A13,19221,132,1.55 [1.04-2.31],0.0306511291799344
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCARB2,Lysosome membrane protein 2,22135,152,2.12 [1.40-3.23],0.0004195321478349
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCARF1,Scavenger receptor class F member 1,22983,159,1.61 [1.17-2.21],0.0034294258072301
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SDC1,Syndecan-1,22711,157,1.83 [1.38-2.44],3.0691926523299755e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEC31A,Protein transport protein Sec31A,19267,128,1.29 [1.02-1.62],0.0323443228526089
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEL1L,Protein sel-1 homolog 1,19267,128,1.65 [1.22-2.22],0.0011158941667052
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SELE,E-selectin,22983,159,1.45 [1.09-1.92],0.0109256033383577
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SELL,L-selectin,19799,134,3.48 [2.05-5.89],3.7724730066298393e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEMA3G,Semaphorin-3G,19358,132,1.92 [1.37-2.70],0.0001565627879573
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEMA4D,Semaphorin-4D,22906,153,2.56 [1.59-4.15],0.0001243526524762
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEMA6C,Semaphorin-6C,19221,132,1.60 [1.01-2.54],0.0443104424028329
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEMA7A,Semaphorin-7A,22915,159,3.39 [2.57-4.48],6.705821398376314e-18
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEPTIN3,Neuronal-specific septin-3,19741,135,0.78 [0.61-0.99],0.0392473528626447
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEPTIN7,Septin-7,19390,131,1.29 [1.04-1.61],0.0222205820197853
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEPTIN8,Septin-8,19691,135,1.92 [1.25-2.95],0.0029500997769931
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA5,Plasma serine protease inhibitor,19494,133,0.43 [0.24-0.77],0.0047737073931922
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA7,Thyroxine-binding globulin,19799,134,2.41 [1.04-5.57],0.0403343301318587
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA9,Serpin A9,22473,153,2.06 [1.77-2.41],8.551439337485384e-20
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINB8,Serpin B8,22959,157,1.36 [1.14-1.62],0.0006922723617892
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINE2,Glia-derived nexin,19770,134,1.42 [1.11-1.81],0.0055869327028764
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SFTPA2,Pulmonary surfactant-associated protein A2,22194,151,1.31 [1.00-1.71],0.0482434470606745
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SH2D1A,SH2 domain-containing protein 1A,22671,156,1.30 [1.07-1.58],0.0075626951570183
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SHISA5,Protein shisa-5,19766,134,2.45 [1.70-3.51],1.2442068145666212e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC1,Sialoadhesin,22813,156,1.85 [1.37-2.51],7.33879857968578e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC10,Sialic acid-binding Ig-like lectin 10,22671,156,5.23 [3.74-7.30],2.6966970761731293e-22
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC15,Sialic acid-binding Ig-like lectin 15,22146,152,1.20 [1.04-1.39],0.0137617392803598
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC5,Sialic acid-binding Ig-like lectin 5,22717,155,1.43 [1.21-1.69],2.997642377196074e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC6,Sialic acid-binding Ig-like lectin 6,22910,156,3.23 [2.50-4.17],3.3628731046184922e-19
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC8,Sialic acid-binding Ig-like lectin 8,19267,128,1.83 [1.27-2.65],0.0012691645099208
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIRPB1,Signal-regulatory protein beta-1,22670,156,2.01 [1.48-2.71],5.654181594216149e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIRT1,NAD-dependent protein deacetylase sirtuin-1,19221,132,1.19 [1.03-1.38],0.0214708098395123
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLAMF1,Signaling lymphocytic activation molecule,22280,152,1.35 [1.05-1.74],0.0212204874528463
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLAMF6,SLAM family member 6,22194,151,2.36 [1.74-3.19],2.6360213440402424e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLAMF7,SLAM family member 7,22671,156,1.41 [1.11-1.78],0.005009709736231
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLAMF8,SLAM family member 8,22194,151,1.81 [1.39-2.35],1.1567794494253525e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC16A1,Monocarboxylate transporter 1,22146,152,1.27 [1.05-1.55],0.0159643805491109
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLITRK2,SLIT and NTRK-like protein 2,22910,156,1.61 [1.11-2.33],0.0125455632121498
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLITRK6,SLIT and NTRK-like protein 6,22305,153,1.79 [1.24-2.59],0.0019461958633979
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMAD3,Mothers against decapentaplegic homolog 3,19665,134,1.37 [1.01-1.86],0.04560501429758
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMC3,Structural maintenance of chromosomes protein 3,19073,128,1.36 [1.08-1.69],0.0075464744827303
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMNDC1,Survival of motor neuron-related-splicing factor 30,19671,134,1.25 [1.01-1.54],0.0423316953565456
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMOC1,SPARC-related modular calcium-binding protein 1,22910,156,1.60 [1.05-2.43],0.0291496337252762
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMPD1,Sphingomyelin phosphodiesterase,22792,152,1.43 [1.07-1.91],0.0166199406889581
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMPD3,Sphingomyelin phosphodiesterase 3,19221,132,1.39 [1.15-1.67],0.0005031697450769
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNRPB2,U2 small nuclear ribonucleoprotein B'',19732,135,1.37 [1.09-1.72],0.006340535173997
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNX18,Sorting nexin-18,19671,134,1.43 [1.05-1.94],0.0221735117188605
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNX2,Sorting nexin-2,19665,134,1.20 [1.00-1.45],0.04741064380206
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNX5,Sorting nexin-5,19267,128,1.67 [1.02-2.71],0.0407129778702743
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SORCS2,VPS10 domain-containing receptor SorCS2,22194,151,1.74 [1.17-2.58],0.0057459403241842
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPESP1,Sperm equatorial segment protein 1,19770,134,2.67 [1.63-4.38],9.99338623374733e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINK1,Serine protease inhibitor Kazal-type 1,22717,155,1.49 [1.10-2.00],0.0089464574008397
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINK2,Serine protease inhibitor Kazal-type 2,19358,132,2.04 [1.39-3.00],0.0002888082348444
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINK4,Serine protease inhibitor Kazal-type 4,22671,156,1.53 [1.26-1.85],1.5146494764968872e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINT1,Kunitz-type protease inhibitor 1,22651,153,2.01 [1.20-3.37],0.0078837757349028
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINT2,Kunitz-type protease inhibitor 2,22813,156,1.53 [1.08-2.17],0.0171664004194514
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",19221,132,1.61 [1.21-2.14],0.0012380810030928
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPRING1,SREBP regulating gene protein,19073,128,1.27 [1.02-1.59],0.0322898523734604
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPTLC1,Serine palmitoyltransferase 1,19732,135,1.70 [1.31-2.21],7.924963883426077e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",22983,159,1.61 [1.01-2.58],0.046487787510783
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",19221,132,1.33 [1.04-1.72],0.0260587944184352
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STAM,Signal transducing adapter molecule 1,19665,134,1.44 [1.00-2.06],0.0473192564585943
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STAT2,Signal transducer and activator of transcription 2,19221,132,1.28 [1.04-1.59],0.0218832166384561
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STC1,Stanniocalcin-1,22906,153,2.31 [1.78-2.98],1.7411158276237647e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STX8,Syntaxin-8,22671,156,1.39 [1.08-1.80],0.0118820123556173
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SWAP70,Switch-associated protein 70,19671,134,1.90 [1.45-2.51],4.59201108416795e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TALDO1,Transaldolase,19683,134,1.45 [1.03-2.04],0.0332516643563446
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TBC1D17,TBC1 domain family member 17,22146,152,1.33 [1.03-1.72],0.0304665347022623
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TBCA,Tubulin-specific chaperone A,19358,132,1.26 [1.04-1.52],0.0161633513434766
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TCN2,Transcobalamin-2,22944,159,1.59 [1.07-2.35],0.0215732248797161
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TCOF1,Treacle protein,19770,134,2.37 [1.81-3.12],5.414093902105743e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TDP1,Tyrosyl-DNA phosphodiesterase 1,19665,134,1.31 [1.10-1.56],0.0025677111817671
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TET2,Methylcytosine dioxygenase TET2,19354,131,1.19 [1.05-1.35],0.0062819994084054
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TFF1,Trefoil factor 1,22605,153,1.25 [1.06-1.48],0.0068706784199453
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TFF2,Trefoil factor 2,22774,156,1.29 [1.02-1.64],0.0338128485957369
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TFPI2,Tissue factor pathway inhibitor 2,22705,154,1.35 [1.01-1.81],0.0413350942583362
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TFRC,Transferrin receptor protein 1,22784,156,1.43 [1.01-2.03],0.0433691637986897
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGFB1,Transforming growth factor beta-1 proprotein,22918,156,1.65 [1.17-2.32],0.0046149462486102
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGFBR2,TGF-beta receptor type-2,22777,154,2.14 [1.45-3.15],0.0001156083518341
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THBD,Thrombomodulin,22711,157,2.69 [1.68-4.32],3.953580371374764e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THOP1,Thimet oligopeptidase,22608,157,1.71 [1.12-2.60],0.0128612748865245
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIE1,Tyrosine-protein kinase receptor Tie-1,22983,159,1.54 [1.03-2.30],0.0347806476619433
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",22098,152,1.52 [1.17-1.98],0.0016185400616124
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,19390,131,2.08 [1.71-2.52],9.469635808639053e-14
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,22773,157,1.46 [1.07-2.00],0.0167378543015442
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIMP1,Metalloproteinase inhibitor 1,22437,156,1.98 [1.28-3.07],0.0021161248764171
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIMP4,Metalloproteinase inhibitor 4,22717,155,0.64 [0.44-0.92],0.016066488712187
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TINAGL1,Tubulointerstitial nephritis antigen-like,22635,156,2.36 [1.27-4.37],0.0066218074634672
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TK1,"Thymidine kinase, cytosolic",19390,131,1.54 [1.18-1.99],0.0012665834168283
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMPRSS5,Transmembrane protease serine 5,22450,153,1.48 [1.01-2.17],0.0451040790201
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMSB10,Thymosin beta-10,22717,155,1.21 [1.01-1.47],0.0432711156925533
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNC,Tenascin,22773,157,1.45 [1.09-1.93],0.0110713092363957
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNF,Tumor necrosis factor,22264,153,1.87 [1.61-2.16],5.2244667869730025e-17
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,22558,153,2.19 [1.68-2.84],4.924781144633589e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,22558,153,1.45 [1.26-1.66],1.917865214047389e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,22745,158,1.35 [1.01-1.81],0.044144012716919
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,22959,157,1.84 [1.31-2.60],0.0004460808706424
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,22746,156,5.01 [3.97-6.33],8.901420475574623e-42
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,22280,152,3.66 [3.12-4.30],3.142227133201294e-56
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,22746,156,2.60 [1.71-3.96],7.916965153807736e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,19358,132,3.15 [2.13-4.65],8.07640428972757e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,22910,156,1.86 [1.22-2.86],0.0043174511603803
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,22717,155,2.43 [1.58-3.73],5.503602715220441e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,22717,155,1.83 [1.54-2.16],2.77006238746095e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,22918,156,5.43 [4.30-6.86],7.389222402168074e-46
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,22558,153,1.69 [1.39-2.05],1.7983631201726437e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,22906,153,2.77 [2.26-3.41],2.7305154642814715e-22
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,22558,153,5.29 [4.45-6.29],1.0678674241747952e-78
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFSF10,Tumor necrosis factor ligand superfamily member 10,22959,157,2.16 [1.25-3.71],0.0054582519764321
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFSF11,Tumor necrosis factor ligand superfamily member 11,22671,156,1.56 [1.24-1.96],0.0001714534529797
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFSF8,Tumor necrosis factor ligand superfamily member 8,19766,134,3.20 [2.27-4.50],2.44659416778974e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TOP2B,DNA topoisomerase 2-beta,19221,132,1.27 [1.05-1.55],0.015971717853721
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TOR1AIP1,Torsin-1A-interacting protein 1,19267,128,1.37 [1.07-1.75],0.0127094215164889
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPK1,Thiamin pyrophosphokinase 1,19770,134,3.09 [1.75-5.47],0.0001038928748574
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPMT,Thiopurine S-methyltransferase,22194,151,1.28 [1.08-1.52],0.0053570318657905
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPP1,Tripeptidyl-peptidase 1,22559,154,1.49 [1.15-1.94],0.0025452728029142
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPR,Nucleoprotein TPR,19168,129,1.32 [1.05-1.67],0.019103726294042
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,19390,131,1.19 [1.01-1.40],0.0403857238910918
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TREML1,Trem-like transcript 1 protein,19775,135,1.41 [1.05-1.89],0.0237828765199021
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TREML2,Trem-like transcript 2 protein,22717,155,2.18 [1.45-3.29],0.0002029785268971
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSC1,Hamartin,19221,132,1.32 [1.13-1.54],0.0004593649322004
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TST,Thiosulfate sulfurtransferase,22108,152,1.22 [1.01-1.46],0.0413518109581472
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TXNDC9,Thioredoxin domain-containing protein 9,19732,135,1.34 [1.01-1.78],0.0407402338911707
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UBAC1,Ubiquitin-associated domain-containing protein 1,22605,154,1.58 [1.07-2.34],0.0222560046837698
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,19770,134,1.59 [1.24-2.05],0.0003195717448397
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,19221,132,1.37 [1.10-1.71],0.0045863722884591
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UBXN1,UBX domain-containing protein 1,19358,132,1.27 [1.00-1.60],0.0480069976899662
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ULBP2,UL16-binding protein 2,22558,153,1.85 [1.30-2.63],0.0006393745656378
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",USP25,Ubiquitin carboxyl-terminal hydrolase 25,19665,134,1.27 [1.01-1.59],0.040691210441329
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",USP28,Ubiquitin carboxyl-terminal hydrolase 28,19732,135,1.59 [1.20-2.12],0.0014744485960014
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VCAM1,Vascular cell adhesion protein 1,22736,157,4.30 [2.87-6.44],1.6727679693975394e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VEGFA,Vascular endothelial growth factor A,22890,157,1.50 [1.20-1.86],0.0003110316198317
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSIG2,V-set and immunoglobulin domain-containing protein 2,19665,134,1.41 [1.11-1.80],0.005715902689013
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSIG4,V-set and immunoglobulin domain-containing protein 4,22684,155,1.81 [1.30-2.51],0.0004027858409471
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WARS,"Tryptophan--tRNA ligase, cytoplasmic",22717,155,1.57 [1.09-2.27],0.0153795759018025
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WASHC3,WASH complex subunit 3,19732,135,1.27 [1.04-1.54],0.0189827434347158
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WFDC1,WAP four-disulfide core domain protein 1,19278,132,1.26 [1.02-1.55],0.0310171231474044
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WFDC2,WAP four-disulfide core domain protein 2,21533,143,2.20 [1.59-3.05],2.093950590008565e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WNT9A,Protein Wnt-9a,22280,152,1.74 [1.13-2.66],0.0113814743319976
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",XCL1,Lymphotactin,22910,156,1.43 [1.20-1.71],9.001050395081532e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZBP1,Z-DNA-binding protein 1,19221,132,1.74 [1.36-2.23],9.858739445307647e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZBTB17,Zinc finger and BTB domain-containing protein 17,22305,153,1.51 [1.17-1.96],0.0016710625077002
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZHX2,Zinc fingers and homeoboxes protein 2,19732,135,1.75 [1.35-2.28],3.145551807756021e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZNF75D,Zinc finger protein 75D,19390,131,1.29 [1.06-1.57],0.0118693900841723
